Loading: 100%
ACELRX PHARMACEUTICALS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 43 (as per Q2 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker ACRXno data available
Financial year endsFY ends End of no data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20172.13
11.10.20175.35
04.10.20175.23
27.09.20174.40
20.09.20173.20
13.09.20173.15
06.09.20173.25
30.08.20173.35
23.08.20173.00
16.08.20173.00
09.08.20173.00
02.08.20172.95
26.07.20173.70
19.07.20173.00
12.07.20172.25
05.07.20172.05
27.06.20172.05
20.06.20172.50
13.06.20172.38
06.06.20172.45
30.05.20172.50
23.05.20172.65
16.05.20172.50
09.05.20172.60
02.05.20172.65
25.04.20172.55
18.04.20172.70
11.04.20172.75
04.04.20173.05
28.03.20173.10
21.03.20172.95
14.03.20173.10
07.03.20173.15
28.02.20173.05
21.02.20173.15
14.02.20173.00
07.02.20173.00
31.01.20172.65
24.01.20172.60
17.01.20172.75
10.01.20172.65
03.01.20172.55
27.12.20162.85
19.12.20162.80
12.12.20162.95
05.12.20162.90
28.11.20163.00
21.11.20163.10
14.11.20163.15
07.11.20162.75
31.10.20162.80
24.10.20163.15
17.10.20163.35
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
2.13n/a
Market Capitalisation
in million USD
97n/a
Enterprise Value
in million USD
19n/a
Common Shares Outstanding
as per Apr 27, 2017
45,380,473n/a
Preferred Shares Outstanding
as per Apr 27, 2017
7,151,802n/a
Average Basic Shares Outstanding
TTM
45,328,463n/a
Average Diluted Shares Outstanding
TTM
45,325,943n/a
Index Membership
n/a
Business Summary
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 99n/a
Receivables 4n/a
Total Current Assets 106n/a
PP&E 8n/a
Total Assets 114n/a
Accounts Payable 3n/a
Current Debt 14n/a
Total Current Liabilities 21n/a
Long-Term Debt 7n/a
Total Liabilities 100n/a
Total Equity 13n/a
Cash Flow
Depreciation & Amortisation 2n/a
Change in Working Capital -1n/a
Operating Cash Flow -13n/a
Net Change in PP&E and Intangibles -1n/a
Investing Cash Flow 13n/a
Dividends Paid 0n/a
Financing Cash Flow 62n/a
Total Change in Cash 62n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.14n/a
Other Ratios
Current Ratio 502.0%n/a
Liabilities to Equity Ratio 741.4%n/a
Debt to Assets Ratio 18.8%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
0
0
1
2
30
5
19
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
-2
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
0
0
1
2
30
5
17
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-19
-12
-20
-32
-36
-43
-37
Selling, General & Administrative
-4
-4
-7
-7
-10
-18
-14
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-16
-8
-14
-25
-26
-25
-22
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-19
-12
-19
-30
-7
-38
-19
Non-Operating Income (Loss)
1
1
2
2
2
3
3
Interest Expense, net
1
1
2
2
2
3
3
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-18
-11
-17
-27
-5
-35
-16
Abnormal Gains (Losses)
0
0
0
0
-15
7
3
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-18
-11
-17
-27
-20
-28
-13
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
-1
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-18
-11
-17
-27
-20
-28
-14
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-18
-11
-17
-27
-20
-28
-14
Minority Interest
0
0
0
0
0
0
0
Net Income
-18
-11
-17
-27
-20
-28
-14
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-18
-11
-17
-27
-20
-28
-14
Remarks
restated on Mar 23, 2012 n/a
calculated values,
restated on Mar 12, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 7, 2016 n/a
calculated values,
restated on Mar 7, 2016 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
4
36
60
104
75
113
Cash & Cash Equivalents
n/a
3
8
48
88
60
108
Short Term Investments
n/a
1
28
12
15
15
6
Accounts & Notes Receivable
n/a
0
0
0
0
0
3
Accounts Receivable, Net
n/a
0
0
0
0
0
3
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
0
0
0
0
0
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
2
2
2
1
1
2
Prepaid Expenses
n/a
2
2
2
1
1
2
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
6
38
62
105
76
119
Property, Plant & Equipment, Net
n/a
1
2
2
5
10
9
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
0
0
0
0
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
Total Noncurrent Assets
n/a
1
3
3
5
10
9
Total Assets
n/a
7
41
65
110
86
128
Liabilities and owners' equity
Payables & Accruals
n/a
1 1402000
4 4041000
7 6888000
6 6245000
6 6085000
6 5517000
Accounts Payable
n/a
1 543000
2 1530000
2 2235000
2 2341000
2 2431000
2 1561000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
1 859000
3 2511000
5 4653000
4 3904000
4 3654000
4 3956000
Short Term Debt
n/a
12 12009000
4 3804000
7 7443000
0 0
7 6859000
5 4541000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
1 623000
1 787000
3 2722000
Deferred Revenue
n/a
0 0
0 0
0 0
1 623000
1 787000
3 2604000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 118000
Total Current Liabilities
n/a
13 13411000
8 7845000
14 14331000
7 6868000
14 13731000
13 12780000
Long Term Debt
n/a
0 0
15 15275000
9 8530000
14 14364000
18 18015000
16 16381000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
3 3370000
0 247000
8 7812000
16 15640000
8 8014000
66 65511000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
2 2007000
2 1626000
1 593000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
3 3370000
0 247000
8 7812000
14 13633000
6 6388000
65 64918000
Total Noncurrent Liabilities
n/a
3 3370000
16 15522000
16 16342000
30 30004000
26 26029000
82 81892000
Total Liabilities
n/a
17 16781000
23 23367000
31 30673000
37 36872000
40 39760000
95 94672000
Preferred Equity
n/a
56 55941000
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
3 2671000
106 106132000
156 155873000
219 218611000
225 225466000
236 236319000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-69 -68563000
-89 -88664000
-122 -122027000
-145 -145453000
-179 -178806000
-203 -203205000
Other Equity
n/a
0 0
0 0
0 1000
0 1000
0 -4000
0 -1000
Equity Before Minority Interest
n/a
-10 -9951000
17 17468000
34 33847000
73 73159000
47 46656000
33 33113000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
-10 -9951000
17 17468000
34 33847000
73 73159000
47 46656000
33 33113000
Total Liabilities & Equity
n/a
7 6830000
41 40835000
65 64520000
110 110031000
86 86416000
128 127785000
Remarks restated on n/a restated on Mar 23, 2012 n/a restated on Mar 12, 2013 n/a restated on Mar 17, 2014 n/a restated on Mar 13, 2015 n/a restated on Mar 7, 2016 n/a restated on Mar 3, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-20
-14
-20
-33
-23
-33
-24
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
1
1
1
1
2
Non-Cash Items
1
3
2
5
19
-2
7
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
0
-2
2
4
3
0
-4
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-19
-12
-15
-25
0
-34
-20
Change in Fixed Assets & Intangibles
0
0
-2
-1
-3
-6
-1
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
-11
5
-30
16
-4
0
10
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
20
0
2
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
9
5
-30
15
-7
-6
8
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
12
3
14
-4
-2
10
56
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
35
53
50
2
3
Increase in Capital Stock
0
0
35
53
50
2
3
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
12
3
50
50
48
12
60
Net Cash Before Disc. Operations and FX
1
-4
5
40
40
-28
48
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
1
-4
5
40
40
-28
48
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
1
-4
5
40
40
-28
48
Remarks
restated on Mar 23, 2012 n/a
calculated values,
restated on Mar 12, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 7, 2016 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo